Literature DB >> 2040473

How prevalent is cancer family syndrome?

F Kee1, B J Collins.   

Abstract

Based on an established but pragmatic definition of cancer family syndrome as the presence of three or more relatives affected by colorectal cancer in a first degree kinship, the contribution of this syndrome to the total cancer burden in Northern Ireland has been studied by investigating all non-polyposis probands under 55 years old at histological diagnosis between 1976 and 1978. Family interviews were possible for 95% (n = 205) of all non-polyposis probands and verification of vital status or medical history was obtained for 98% of 1811 first degree relatives. The prevalence of cancer family syndrome was between 1 and 2%, a figure some fivefold less than that estimated elsewhere. A proximal tumour excess was not characteristic of the ascertained families. These results may have implications for the identification of susceptible people if screening for high risk groups is considered a worthwhile option for reducing colorectal cancer mortality in the United Kingdom.

Entities:  

Mesh:

Year:  1991        PMID: 2040473      PMCID: PMC1378927          DOI: 10.1136/gut.32.5.509

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  21 in total

1.  Frequency of hereditary colorectal carcinoma.

Authors:  J P Mecklin
Journal:  Gastroenterology       Date:  1987-11       Impact factor: 22.682

2.  Genes and carcinogens.

Authors:  A D Spigelman; R K Phillips; S Venitt
Journal:  Lancet       Date:  1989-11-18       Impact factor: 79.321

3.  Factors associated with speed of diagnosis, referral, and treatment in colorectal cancer.

Authors:  C MacArthur; A Smith
Journal:  J Epidemiol Community Health       Date:  1984-06       Impact factor: 3.710

4.  Age-dependent shift-to-the-right in the localization of colorectal adenomas.

Authors:  C D Gerharz; H Gabbert; F Krummel
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

5.  Natural history of hereditary cancer of the breast and colon.

Authors:  W A Albano; J A Recabaren; H T Lynch; A S Campbell; J A Mailliard; C H Organ; J F Lynch; W J Kimberling
Journal:  Cancer       Date:  1982-07-15       Impact factor: 6.860

6.  Clinical features of colorectal carcinoma in cancer family syndrome.

Authors:  J P Mecklin; H J Järvinen
Journal:  Dis Colon Rectum       Date:  1986-03       Impact factor: 4.585

7.  Frequency of hereditary nonpolyposis colorectal carcinoma (Lynch syndromes I and II).

Authors:  H T Lynch
Journal:  Gastroenterology       Date:  1986-02       Impact factor: 22.682

8.  Screening for colorectal carcinoma in cancer family syndrome kindreds.

Authors:  J P Mecklin; H J Järvinen; S Aukee; I Elomaa; K Karjalainen
Journal:  Scand J Gastroenterol       Date:  1987-05       Impact factor: 2.423

9.  Segregation analysis of hereditary nonpolyposis colorectal cancer.

Authors:  J E Bailey-Wilson; R C Elston; G S Schuelke; W Kimberling; W Albano; J F Lynch; H T Lynch
Journal:  Genet Epidemiol       Date:  1986       Impact factor: 2.135

10.  Dietary suppression of colonic cancer. Fiber or phytate?

Authors:  E Graf; J W Eaton
Journal:  Cancer       Date:  1985-08-15       Impact factor: 6.860

View more
  10 in total

Review 1.  The incidence of Lynch syndrome.

Authors:  Albert de la Chapelle
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

2.  Families at risk of colorectal cancer: who are they?

Authors:  F Kee; B J Collins
Journal:  Gut       Date:  1992-06       Impact factor: 23.059

3.  Endoscopic screening of relatives of patients with colorectal cancer.

Authors:  L M Hunt; P S Rooney; J D Hardcastle; N C Armitage
Journal:  Gut       Date:  1998-01       Impact factor: 23.059

4.  Accuracy of reporting of family history of colorectal cancer.

Authors:  R J Mitchell; D Brewster; H Campbell; M E M Porteous; A H Wyllie; C C Bird; M G Dunlop
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

5.  Family history of colorectal cancer in a Sweden county.

Authors:  Louise Olsson; Annika Lindblom
Journal:  Fam Cancer       Date:  2003       Impact factor: 2.375

6.  Familial risk of colo-rectal cancer in a low incidence area in southern Italy.

Authors:  S Centonze; H Boeing; C Leoci; C Bonfiglio; V Guerra; G Misciagna
Journal:  Eur J Epidemiol       Date:  1993-01       Impact factor: 8.082

7.  Clinical heterogeneity of familial colorectal cancer and its influence on screening protocols.

Authors:  H F Vasen; B G Taal; G Griffioen; F M Nagengast; A Cats; F H Menko; W Oskam; J H Kleibeuker; G J Offerhaus; P M Khan
Journal:  Gut       Date:  1994-09       Impact factor: 23.059

8.  Guidance on gastrointestinal surveillance for hereditary non-polyposis colorectal cancer, familial adenomatous polypolis, juvenile polyposis, and Peutz-Jeghers syndrome.

Authors:  M G Dunlop
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

9.  Extracolonic features of familial adenomatous polyposis in patients with sporadic colorectal cancer.

Authors:  M G Dunlop; S M Farrington; V J Bubb; C Cunningham; M Wright; L J Curtis; Z A Butt; E Wright; B W Fleck; D Redhead; R Mitchell; J B Rainey; I M Macintyre; D C Carter; A H Wyllie
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

10.  The effect of family size on estimates of the frequency of hereditary non-polyposis colorectal cancer.

Authors:  A Percesepe; M Anti; L Roncucci; F Armelao; G Marra; M Pahor; C Coco; G Gasbarrini; M Ponz de Leon
Journal:  Br J Cancer       Date:  1995-11       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.